发明名称 |
Fusion proteins of collagen-binding domain and parathyroid hormone |
摘要 |
Fusion proteins containing active agonist or antagonist fragments of parathyroid hormone (PTH) and parathyroid hormone related peptide (PTHrP) coupled to a collagen-binding domain are presented. The fusion proteins can be used to promote bone growth, to promote hair growth, to prevent cancer metastasis to bone, to promote immune reconstitution with a bone marrow stem cell transplant, to promote mobilization of bone marrow stem cells for collection for autologous stem cell transplant, and to treat renal osteodystrophy. Pharmaceutical agents comprising a collagen-binding polypeptide segment linked to a non-peptidyl PTH/PTHrP receptor agonist or antagonist are also presented. |
申请公布号 |
US9528099(B2) |
申请公布日期 |
2016.12.27 |
申请号 |
US201514743629 |
申请日期 |
2015.06.18 |
申请人 |
National University Corporation Kagawa University |
发明人 |
Gensure Robert C.;Sakon Joshua;Matsushita Osamu;Ponnapakkam Tulasi |
分类号 |
A61K38/10;A61K38/16;A61K39/00;C07K14/635;A61K38/29;C12N9/50;C12N9/52;C12N9/64;A61K8/64;A61K8/66;A61K38/48;A61Q7/00 |
主分类号 |
A61K38/10 |
代理机构 |
Andrus Intellectual Property Law, LLP |
代理人 |
Andrus Intellectual Property Law, LLP |
主权项 |
1. A composition comprising:
a collagen-binding polypeptide segment covalently linked to a PTH/PTHrP receptor antagonist; wherein the collagen-binding polypeptide segment is a ColH or ColG bacterial collagen binding polypeptide segment or a segment of a collagenase, wherein the PTH/PTHrP receptor antagonist comprises a peptide selected from the group consisting of residues 7-14 of SFQ ID NO: 7, residues 7-33 of SEQ ID NO: 7, residues 7-34 of SEQ ID NO: 7, residues 7-34 of SEQ ID NO: 8, and SEQ ID NO: 11, wherein the collagen-binding polypeptide segment comprises residues 38-158 of SEQ ID NO: 1, a fragment of at least 8 consecutive amino acids from residues 38-158 of SEQ ID NO: 1 or is at least 90% identical to residues 38-158 of SEQ ID NO: 1. |
地址 |
JP |